Project Grant F30DA060027

Award Date 7/31/24
Completion Date 5/29/27
Dollars Obligated $159K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA

The National Institute on Drug Abuse, through the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a Project Grant for $159,362 to the Regents of the University of Minnesota to investigate the role of the neuropeptide precursor VGF and its derived peptide TLQP-62 in facilitating synaptic plasticity in the nucleus accumbens and their contribution to opioid withdrawal behaviors. The research objectives are to measure the effect of TLQP-62 on synaptic transmission, map the expression of endogenous VGF transcripts, and evaluate the impact of VGF knockout on withdrawal-associated behavioral adaptations in mice. This interdisciplinary study spanning physiology, neuroanatomy, and behavioral assays aims to build an understanding of VGF and TLQP-62 function in the nucleus accumbens and their potential as novel targets for treating opioid use and withdrawal. The project will be conducted at the University of Minnesota from July 2024 through May 2027.

Generated 3/4/25, 7:08 AM